IDEX Corporation

IDEX Corporation (IEX) Market Cap

IDEX Corporation has a market capitalization of $15.31B.

Financials based on reported quarter end 2025-12-31

Price: $205.92

β–² 5.21 (2.60%)

Market Cap: 15.31B

NYSE Β· time unavailable

CEO: Eric D. Ashleman

Sector: Industrials

Industry: Industrial - Machinery

IPO Date: 1989-06-02

Website: https://www.idexcorp.com

IDEX Corporation (IEX) - Company Information

Market Cap: 15.31B Β· Sector: Industrials

IDEX Corporation, together with its subsidiaries, provides applied solutions worldwide. The company operates through three segments: Fluid & Metering Technologies (FMT), Health & Science Technologies (HST), and Fire & Safety/Diversified Products (FSDP). The FMT segment designs, produces, and distributes positive displacement pumps, small volume provers, flow meters, injectors, and other fluid-handling pump modules and systems, as well as offers flow monitoring and other services for the food, chemical, general industrial, water and wastewater, agricultural, and energy industries. The HST segment designs, produces, and distributes precision fluidics, rotary lobe pumps, centrifugal and positive displacement pumps, roll compaction and drying systems, pneumatic components and sealing solutions, high performance molded and extruded sealing components, custom mechanical and shaft seals, engineered hygienic mixers and valves, biocompatible medical devices and implantables, air compressors and blowers, optical components and coatings, laboratory and commercial equipment, precision photonic solutions, and precision gear and peristaltic pump technologies. This segment serves food and beverage, pharmaceutical and biopharmaceutical, cosmetics, marine, chemical, wastewater and water treatment, life sciences, research, and defense markets. The FSDP segment designs, produces, and distributes firefighting pumps, valves and controls, rescue tools, lifting bags, and other components and systems for the fire and rescue industry; engineered stainless steel banding and clamping devices for various industrial and commercial applications; and precision equipment for dispensing, metering, and mixing colorants and paints used in retail and commercial businesses. IDEX Corporation was incorporated in 1987 and is headquartered in Northbrook, Illinois.

Analyst Sentiment

72%
Strong Buy

Based on 15 ratings

Analyst 1Y Forecast: $214.88

Average target (based on 4 sources)

Consensus Price Target

Low

$214

Median

$240

High

$247

Average

$237

Potential Upside: 14.9%

Price & Moving Averages

Loading chart...

πŸ“˜ Full Research Report

ℹ️

AI-Generated Research: This report is for informational purposes only.

πŸ“˜ IDEX Corporation (IEX) β€” Investment Overview

🧩 Business Model Overview

IDEX Corporation is a diversified industrial company specializing in the design and manufacture of highly engineered products and systems. Its broad portfolio encompasses fluid and metering technologies, health and science instruments, fire and safety products, and other specialty engineered solutions. IDEX serves a wide-ranging customer base in sectors such as life sciences, industrial manufacturing, fire & rescue, agriculture, water treatment, and energy. The company primarily operates through decentralized business units, allowing for strong customer intimacy and nimbleness in responding to end-market demands.

πŸ’° Revenue Model & Ecosystem

IDEX generates revenue through multiple streams: the sale of proprietary hardware components and integrated systems, aftermarket parts and consumables, as well as ongoing technical services and support. Solutions are tailored for enterprise and institutional clients, where performance and application-specific requirements drive purchasing decisions. Long product life cycles and an emphasis on reliability create opportunities for recurring revenue via service contracts, retrofit solutions, and upgrades, further embedded within the client’s operational value chain.

🧠 Competitive Advantages

  • Brand strength: IDEX’s product brands are recognized as leaders in their respective niches, often synonymous with quality, reliability, and innovation.
  • Switching costs: The mission-critical nature of IDEX’s components, especially in safety, scientific, and manufacturing applications, creates high switching costs for customers after initial adoption.
  • Ecosystem stickiness: Integration of IDEX’s hardware with supporting software, services, and consumables fosters long-term relationships and greater customer retention.
  • Scale + supply chain leverage: The company’s global reach and operational scale allow it to optimize sourcing, manufacturing, and distribution, outpacing smaller competitors and benefiting from cost efficiencies.

πŸš€ Growth Drivers Ahead

Key growth drivers for IDEX revolve around both organic innovation and targeted acquisition strategies. Advances in life sciences, analytical instrumentation, and automation present new market opportunities. The increasing need for precision fluids handling, traceability, and process safety across industries further expands IDEX’s addressable market. Strategic acquisitions are a hallmark, targeting high-value niche companies that enhance or complement existing technology platforms. Expansion into emerging markets, increased investment in digital solutions, and a focus on sustainability also act as long-term growth levers.

⚠ Risk Factors to Monitor

IDEX operates in highly competitive markets, with risks of price competition and technological disruption from both established and emerging players. Regulatory changes, particularly in health sciences and safety, may require product redesigns or impact addressable markets. Margin pressure can arise from raw material cost fluctuations, supply chain disruptions, or customer pricing negotiations. Additionally, execution risk in integrating acquisitions and maintaining decentralized operating performance must be monitored.

πŸ“Š Valuation Perspective

Historically, the market assigns IDEX a valuation reflecting its reputation for operational excellence, high quality of earnings, and defensive end-market exposures. Compared to industrial peers, IDEX often trades at a premium, attributed to its resilient cash flows, niche leadership, and consistent capital allocation strategy. Investors tend to value the company’s combination of organic and acquired growth, as well as its focus on high-margin, low cyclicality businesses.

πŸ” Investment Takeaway

IDEX Corporation stands out as a high-quality, mission-critical industrial solutions provider with strong defensible advantages and compelling multi-year growth opportunities. Its proven strategy of organic innovation supplemented by disciplined acquisitions underpins a robust, diversified portfolio. On the bullish side, its niche focus and reliable cash flows make it a favored pick for long-term compounding. On the bearish side, high valuation expectations, competition, and integration risks warrant careful monitoring. Investors should weigh the company’s resilience and growth prospects against potential sectoral headwinds and execution challenges.


⚠ AI-generated research summary β€” not financial advice. Validate using official filings & independent analysis.

IDEX delivered a better-than-expected Q4 with modest organic growth, margin expansion, and strong HST momentum tied to data center/AI, semiconductor, and defense end markets. Record HST orders boosted backlog and visibility, while FMT and FSDP continued to face industrial and international headwinds. 2026 guidance is prudent with 1%–2% organic growth and solid margins, reflecting strength in HST offset by flat-to-down expectations elsewhere. Management remains disciplined on 8020 execution, bolt-on M&A, and shareholder returns, while acknowledging macro uncertainty and limited signs of an industrial inflection.

Growth

  • Q4 organic sales +1% YoY; organic orders +16% YoY
  • HST Q4 organic orders +34% YoY to a record ~$493M; HST revenue +5% YoY
  • FMT Q4 organic orders +4% YoY; organic sales +1% YoY
  • FSDP Q4 organic orders flat YoY; organic sales -5% YoY
  • FY2025 organic revenue +1%; free cash flow +2% YoY to $617M

Business Development

  • Acquired Microlam (bolt-on) adding proprietary precision forming for optics; integration progressing; largely booked for 2026; capacity expansion underway
  • Cross-business collaboration in data center liquid cooling and behind-the-meter power (blowers, vacuum pumps, valves) leveraging shared APAC capabilities
  • Material Science Solutions platform expanding in space & defense, semiconductor, and data center communications
  • Coordinated commercial efforts across Life Sciences, MSS, and Mott to target common customers
  • 8020 playbook guiding resource allocation and product/customer segmentation

Financials

  • Q4 adjusted EBITDA margin +40 bps YoY; adjusted gross margin flat YoY
  • HST adjusted EBITDA margin +60 bps YoY; FMT -20 bps; FSDP +50 bps
  • Price positive across all segments; Q4 volumes flat at HST and down at FMT/FSDP
  • Platform optimization and cost containment delivered ~$60M savings in 2025
  • FY2025 free cash flow $617M (103% conversion of adjusted net income); liquidity ~ $1.1B

Capital & Funding

  • Repurchased ~$73M of shares in Q4; ~$250M (1.4M shares) in 2025
  • Paid ~$213M in dividends in 2025; dividend payout target 30%–35% of adjusted net income maintained
  • Reduced gross leverage from ~2.2x to ~2.0x in 2025; maintain investment-grade rating
  • Capital deployment priorities: strong balance sheet, organic investment, bolt-on M&A (integration focus near term), ongoing buybacks

Operations & Strategy

  • Advancing phase 3 strategy to build scalable growth platforms in targeted advantage markets
  • 8020-driven mix upgrades and simplification to support margin expansion, particularly within HST
  • Applying IDEX operating model to accelerate integration and capacity scaling (e.g., Microlam)
  • Targeting AI-related data center ecosystem, semiconductor consumables, and optical switching
  • Municipal water and food/pharma supported by materials processing technologies; semicon sealing benefiting from memory demand

Market & Outlook

  • FY2026 guidance: organic growth +1% to +2%; adjusted EBITDA margin 26%–27%; adjusted EPS $8.15–$8.35; tax rate ~24%
  • Segment outlook 2026: HST mid-single-digit growth; FMT and FSDP flat to slightly down
  • Q1 2026 guide: organic growth ~+1%; adjusted EBITDA margin ~24.5%; adjusted EPS $1.73–$1.78 (seasonally softest quarter)
  • Expect sequential sales uptick in Q2 with stronger earnings leverage
  • Overall booking visibility ~50% entering a quarter; HST backlog provides above-average visibility; FMT/FSDP visibility limited to mid-quarter due to rapid fulfillment

Risks Or Headwinds

  • No clear inflection in broad industrial demand; PMI backdrop has been contracting
  • Softness in chemical, oil & gas, and agriculture (over one-third of FMT exposure)
  • Weakness in fire & safety outside the U.S.; subdued capital spending in dispensing
  • Volume deleverage and unfavorable mix pressures in FMT and FSDP
  • Policy volatility and macro uncertainty; seasonal Q1 demand softness
  • Industrial/auto exposures within HST (~20% of segment) flattish

Sentiment: CAUTIOUS

Note: This summary was synthesized by AI from the IEX Q4 2025 earnings transcript. Financial data is complex; please verify all metrics against official SEC filings before making investment decisions.

Fundamentals Overview

Loading fundamentals overview...

πŸ“Š AI Financial Analysis

Powered by StockMarketInfo
Earnings Data: Q Ending 2025-12-31

"IEX reported a quarterly revenue of $899.1 million with an EPS of $1.72, reflecting a net margin of 14.3%. The company generated an impressive free cash flow of $209.5 million, highlighting robust liquidity. Year-over-year growth reflects a steady performance with modest improvement in profitability. The balance sheet is strong, with net debt at a negative $579.3 million indicating a net cash position, supporting financial resilience. Shareholder returns include consistent dividends amounting to $0.71 per quarter. Analyst sentiment suggests positivity with a median price target of $210.5. Valuation metrics were not provided, but overall, the financial health and cash generation ability of IEX appear robust, balancing its growth and returning value to shareholders."

Revenue Growth

Positive

Revenue growth is steady, with the company maintaining a stable trajectory. Consistent revenue streams provide a reliable base for operations and growth.

Profitability

Good

Net margin is healthy at 14.3%, and EPS shows a positive trend, indicating efficient operations and effective cost management.

Cash Flow Quality

Strong

Free cash flow is strong at $209.5 million, with no capex indicating efficient cash management. Absence of buybacks or debt repayments suggests focus on liquidity preservation.

Leverage & Balance Sheet

Strong

With net debt in a negative position, the company shows strong balance sheet health, signaling excellent financial resilience.

Shareholder Returns

Positive

Shareholder returns mainly through dividends are steady. No buybacks this quarter, but consistent dividend payments enhance shareholder value.

Analyst Sentiment & Valuation

Positive

Analyst sentiment is positive with a consensus price target that suggests appreciation potential. Lack of specific valuation metrics limits more precise evaluation.

Disclaimer:This analysis is AI-generated for informational purposes only. Accuracy is not guaranteed and this does not constitute financial advice.

Loading financial data and tables...
πŸ“

SEC Filings (IEX)

Β© 2026 Stock Market Info β€” IDEX Corporation (IEX) Financial Profile